Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon Cancer Patients in England

被引:0
|
作者
Syreen Hassan
Anne Miles
Bernard Rachet
Melanie Morris
机构
[1] Department of Health Services Research and Policy,Department of Psychological Sciences
[2] London School of Hygiene and Tropical Medicine,Department of Non
[3] Birkbeck,communicable Disease Epidemiology
[4] University of London,undefined
[5] London School of Hygiene and Tropical Medicine,undefined
来源
关键词
Adjuvant chemotherapy; Colon cancer; Fluoropyrimidine; Oxaliplatin; Inequalities;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1193 / 1201
页数:8
相关论文
共 50 条
  • [21] Less Adjuvant Chemotherapy for Elderly Patients With Stage III Colon Cancer in the Netherlands
    van Steenbergen, L. N.
    Lemmens, V. E. P. P.
    Rutten, H. J. T.
    Wymenga, A. N. M.
    Nortier, J. W. R.
    Janssen-Heijnen, M. L. G.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S275 - S276
  • [22] Survival outcomes of adjuvant chemotherapy in elderly patients with stage III colon cancer
    Shaib, Walid Labib
    Khalil, Lana
    Akce, Mehmet
    Switchenko, Jeffrey M.
    Gao, Xingyu
    Diab, Maria
    Wu, Christina
    Alese, Olatunji B.
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [23] Adjuvant chemotherapy for stage III colon cancer in the oldest old
    Abraham, Anasooya
    Habermann, Elizabeth B.
    Rothenberger, David A.
    Kwaan, Mary
    Weinberg, Armin D.
    Parsons, Helen M.
    Gupta, Pankaj
    Al-Refaie, Waddah B.
    CANCER, 2013, 119 (02) : 395 - 403
  • [24] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer REPLY
    Shi, Qian
    Paul, James
    Grothey, Axel
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 396 - 397
  • [25] Refining the role of adjuvant chemotherapy in stage III colon cancer
    Tanis, Pieter J.
    COLORECTAL DISEASE, 2019, 21 (02) : 135 - 136
  • [26] Survival of Adjuvant Chemotherapy Among Elderly Patients with Stage II Colon Cancer
    Tsai, Tsung-Chih
    Sun, Jia-Ling
    Lin, Wen-Li
    Lee, Sung-Wei
    Chang, Shu-Chan
    Wu, Pei-Hua
    Huang, Wen-Tsung
    Tsao, Chao-Jung
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2018, 12 (02) : 94 - 99
  • [27] The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
    Hsieh, Mei-Chin
    Thompson, Trevor
    Wu, Xiao-Cheng
    Styles, Timothy
    O'Flarity, Mary B.
    Morris, Cyllene R.
    Chen, Vivien W.
    CANCER MEDICINE, 2016, 5 (05): : 871 - 880
  • [28] Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patients
    van Erning, F. N.
    Razenberg, L. G. E. M.
    Lemmens, V. E. P. P.
    Creemers, G. J.
    Pruijt, J. F. M.
    Maas, H. A. A. M.
    Janssen-Heijnen, M. L. G.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : 1 - 10
  • [29] Molecular characterization of stage III colon cancer patients with recurrence after adjuvant chemotherapy
    Franken, Ingrid
    Ketelaars, Steven
    Rubio-Alarcon, Carmen
    van Nassau, Sietske
    Schraa, Suzanna
    Meijer, Gerrit
    Sausen, Mark
    Koopman, Miriam
    Vink, Geraldine
    Abeln, Sanne
    Fijneman, Remond
    Roodhart, Jeanine
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer
    Kumar, Aalok
    Peixoto, Renata D.
    Kennecke, Hagen F.
    Renouf, Daniel J.
    Lim, Howard J.
    Gil, Sharlene
    Speers, Caroline H.
    Cheung, Winson Y.
    CLINICAL COLORECTAL CANCER, 2015, 14 (04) : 262 - 268